| GTO ID | GTC0991 |
| Trial ID | ChiCTR2200058969 |
| Disease | T-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase Ia/Ib, multicenter, open, non-randomized, single-arm clinical trial of humanized different-targeted chimeric antigen receptor T cells in the treatment of relapsed/refractory T-cell lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Beijing Gaobo Boren Hospital |
| Cohort 1 | |||||||
|
|||||||